(Q47915281)

English

Brief Report: Drug-Free Long-Term Remission in Severe Behçet's Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment

scientific article published on 22 August 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

Brief Report: Drug-Free Long-Term Remission in Severe Behçet's Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

Behçet's disease

0 references

Maria G Tektonidou

object named as

Maria Tektonidou

7

0 references

Petros P Sfikakis

1

object named as

Petros P Sfikakis

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

Stylianos Panopoulos

3

object named as

Stylianos Panopoulos

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

George Pentazos

5

object named as

George Pentazos

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

Aikaterini Arida

2

object named as

Aikaterini Arida

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

Kalliopi Fragiadaki

4

object named as

Kalliopi Fragiadaki

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

Katerina Laskari

6

object named as

Katerina Laskari

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

author name string

Nikos Markomichelakis

8

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

publication date

22 August 2017

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

Arthritis & Rheumatology

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

69

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

12

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

2380-2385

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

Mortality in Behçet's disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

EULAR recommendations for the management of Behçet disease

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Infliximab is a plausible alternative for neurologic complications of Behçet disease

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FART.40235

21 January 2018

Identifiers

10.1002/ART.40235

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/28834393

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47915281&oldid=2175680641"